Medicinal Cannabis Matters: Friday Roundup - 24 April 2026

Reducing Reliance on Traditional Medication

New data reported by Leafie suggests that medicinal cannabis may play a significant role in reducing reliance on traditional prescription medications. According to the findings, 85% of patients reported cutting down their use of other prescribed drugs after starting medicinal cannabis treatment.

For many patients living with chronic conditions, this is a key outcome. Managing multiple medications can be complex, often accompanied by side effects and limited long-term effectiveness. Under clinical supervision, medicinal cannabis may offer an alternative approach that supports symptom control while simplifying treatment plans.

While further research is always important, real-world data like this provides valuable insight into how patients are experiencing care in practice.

Political Support for Patient Protection in Wales

In Wales, a new motion has been passed by the Welsh Liberal Democrats aimed at improving protections for medicinal cannabis patients. Reported by Cannabis Health News, the motion focuses on ensuring that patients prescribed medicinal cannabis are treated fairly and are not disadvantaged in areas such as employment or public life.

Despite legalisation in 2018, many patients still face uncertainty or misunderstanding when it comes to their rights. Political recognition of these challenges is an important step forward, helping to build a more supportive and informed environment for those accessing treatment.

As awareness grows, continued engagement at policy level will be key to ensuring that legal access translates into practical, everyday support for patients.

The US Expands Access To Medicinal Cannabis

Internationally, the United States has taken steps to ease access to medicinal cannabis, with changes aimed at simplifying regulations and improving availability for patients.

These developments are part of a broader shift towards more accessible cannabis infrastructure. While healthcare systems differ, changes in large markets like the US often influence global research and regulatory thinking.

For UK patients, international progress contributes to a growing evidence base and supports a wider movement towards more consistent, patient-focused care.

This week’s updates reflect a sector that is continuing to evolve with patients at its centre. From reducing reliance on multiple medications to improving legal protections and expanding access internationally, each development supports a more balanced and informed approach to care.

As medicinal cannabis becomes more widely understood, the focus remains on safe prescribing and ensuring that patients have access to treatment options that genuinely improve quality of life.

If you are considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online. The process is confidential and provides a clear starting point before speaking with a specialist clinician.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.